HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Rubenstein, R. Articles by Papini, M. C. Search for Related Content PubMed PubMed Citation Articles by Rubenstein, R. Articles by Papini, M. C. Agricola Articles by Rubenstein, R. Articles by Papini, M. C.

Alterations in neurotransmitter-related enzyme activity in scrapie-infected PC12 cells

Department of Virology, New York State Office of Mental Retardation and Developmental Disabilities, Institute for Basic Research in Developmental Disabilities, 1050 Forest Hill Road, Staten Island, New York 10314, U.S.A.

Enzyme activities associated with the neurotransmitter pathways in nerve growth factor-treated, 139A scrapie strain-infected PC12 cells were examined. Since these cells show no morphological alterations during the time of agent replication, any scrapie-induced effects would have to be associated with non-vital cellular functions. When compared to controls, infection with the 139A scrapie strain resulted in decreased activity of the cholinergic pathway-related enzymes, choline acetyltransferase and acetylcholinesterase. However, the adrenergic pathway was unaffected by scrapie infection as evidenced by unaltered tyrosine hydroxylase activity, the putative rate-limiting enzyme in the synthesis of catecholamines. The effects of the 139A scrapie strain on the cholinergic system appeared to be dose-dependent and were first detected prior to the detection of scrapie agent replication in these cells. Furthermore, the altered enzymic activities observed were not the result of contaminating material in the scrapie brain homogenate because similar results were obtained when partially purified scrapie preparations were used as the inoculum. These scrapie agent-induced alterations in specific neuronal properties suggest a mechanism for the clinical manifestations observed in scrapie and perhaps other related central nervous system disorders.

Received 2 January 1991; accepted 22 February 1991.

This article has been cited by other articles:

				M. Alfa Cisse, C. Sunyach, B. E. Slack, A. Fisher, B. Vincent, and F. Checler M1 and M3 Muscarinic Receptors Control Physiological Processing of Cellular Prion by Modulating ADAM17 Phosphorylation and Activity J. Neurosci., April 11, 2007; 27(15): 4083 - 4092. [Abstract] [Full Text] [PDF]

				J. Solassol, C. Crozet, and S. Lehmann Prion propagation in cultured cells Br. Med. Bull., June 1, 2003; 66(1): 87 - 97. [Abstract] [Full Text] [PDF]

				D. A. Harris Cellular Biology of Prion Diseases Clin. Microbiol. Rev., July 1, 1999; 12(3): 429 - 444. [Abstract] [Full Text] [PDF]

				H. Ovadia, H. Rosenmann, E. Shezen, M. Halimi, I. Ofran, and R. Gabizon Effect of Scrapie Infection on the Activity of Neuronal Nitric-oxide Synthase in Brain and Neuroblastoma Cells J. Biol. Chem., July 12, 1996; 271(28): 16856 - 16861. [Abstract] [Full Text] [PDF]